GlassScriptPhysician profile
Erin Whittington
NPI 1548642804
$5,890.99
in general payments reported to CMS, 2019-2025
37 companies · $927 in 2025
The $927 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,601 · 2022: $1,285 · 2023: $1,052 · 2024: $1,026 · 2025: $927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,960 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,960.00 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $723.25 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $667.58 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $556.70 | 2021-2025 | Mounjaro, Trulicity, Jardiance |
| Abbott Laboratories | $445.54 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Glaxosmithkline, LLC. | $443.43 | 2021-2025 | Trelegy Ellipta, Shingrix, Bexsero |
| Merck Sharp & Dohme LLC | $335.34 | 2021-2025 | Verquvo, Steglatro, Gardasil 9 |
| Abbvie INC. | $323.82 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $319.45 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $291.81 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $194.13 | 2021-2022 | |
| Novo Nordisk INC | $177.01 | 2021-2025 | Ozempic, Rybelsus |
| Amgen INC. | $176.36 | 2024-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $172.01 | 2021-2023 | |
| Exact Sciences Corporation | $154.01 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Corcept Therapeutics | $136.17 | 2023-2025 | Korlym |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Whittington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.